Literature DB >> 7726168

Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8.

J T Hecht1, D Hogue, L C Strong, M F Hansen, S H Blanton, M Wagner.   

Abstract

Hereditary multiple exostosis (EXT) is an autosomal dominant disorder characterized by bony exostoses at the ends of the long bones. Linkage studies have recently suggested that there are three chromosomal locations for EXT genes, 8q24.1 (EXT1), the pericentric region of 11 (EXT2), and 19p (EXT3). As part of a larger study to determine the frequencies of the three EXT types in the United States, we have ascertained a large multigenerational family with EXT and one family member with a chondrosarcoma. This family demonstrated linkage of the disease to chromosome 11 markers. The constitutional and tumor DNAs from the affected family member were compared using short-tandem-repeat markers from chromosomes 8, 11, and 19. Loss of heterozygosity (LOH) in the tumor was observed for chromosome 8 and 11 markers, but chromosome 19 markers were intact. An apparent deletion of the marker D11S903 was observed in constitutional DNA from all affected individuals and in the tumor sample. These results indicate that the EXT2 gene maps to the region containing marker D11S903, which is flanked by markers D11S1355 and D11S1361. Additional constitutional and chondrosarcoma DNA pairs from six unrelated individuals, two of whom had EXT, were similarly analyzed. One tumor from an individual with EXT demonstrated LOH for chromosome 8 markers, and a person with a sporadic chondrosarcoma was found to have tumor-specific LOH and a homozygous deletion of chromosome 11 markers. These findings suggest that EXT genes may be tumor-suppressor genes and that the initiation of tumor development may follow a multistep model.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726168      PMCID: PMC1801450     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcoma.

Authors:  H Scheffer; Y C Kruize; J Osinga; G Kuiken; J W Oosterhuis; J A Leeuw; H Schraffordt Koops; C H Buys
Journal:  Cancer Genet Cytogenet       Date:  1991-05

2.  Multiple exostoses in a patient with t(8;11)(q24.11;p15.5).

Authors:  R F Ogle; P Dalzell; G Turner; D Wass; M Y Yip
Journal:  J Med Genet       Date:  1991-12       Impact factor: 6.318

3.  Tricho-rhino-phalangeal syndrome type I with severe mental retardation due to interstitial deletion of 8q23.3-24.13.

Authors:  Y Yamamoto; N Oguro; M Miyao; M Yanagisawa
Journal:  Am J Med Genet       Date:  1989-01

4.  Genetic heterogeneity in families with hereditary multiple exostoses.

Authors:  A Cook; W Raskind; S H Blanton; R M Pauli; R G Gregg; C A Francomano; E Puffenberger; E U Conrad; G Schmale; G Schellenberg
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

5.  Parental origin of mutations of the retinoblastoma gene.

Authors:  T P Dryja; S Mukai; R Petersen; J M Rapaport; D Walton; D W Yandell
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

6.  Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q.

Authors:  T Yamaguchi; J Toguchida; T Yamamuro; Y Kotoura; N Takada; N Kawaguchi; Y Kaneko; Y Nakamura; M S Sasaki; K Ishizaki
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

7.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Cancer. Gene losses in human tumours.

Authors:  B Ponder
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

9.  The tricho-rhino-phalangeal syndrome(s): chromosome 8 long arm deletion: is there a shortest region of overlap between reported cases? TRP I and TRP II syndromes: are they separate entities?

Authors:  E M Bühler; N J Malik
Journal:  Am J Med Genet       Date:  1984-09

10.  First cytogenetic evidence of homozygosity for the retinoblastoma deletion in chromosome 13.

Authors:  N Lemieux; J Milot; M Barsoum-Homsy; J Michaud; T K Leung; C L Richer
Journal:  Cancer Genet Cytogenet       Date:  1989-11
View more
  46 in total

1.  A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses.

Authors:  Kazu Matsumoto; Fumitoshi Irie; Susan Mackem; Yu Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  A middle-aged man with persisting chest opacity and multiple bony swellings.

Authors:  Prem Parkash Gupta; Dipti Agarwal
Journal:  CMAJ       Date:  2006-11-07       Impact factor: 8.262

3.  Genotype-phenotype correlation in hereditary multiple exostoses.

Authors:  C Francannet; A Cohen-Tanugi; M Le Merrer; A Munnich; J Bonaventure; L Legeai-Mallet
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

4.  Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.

Authors:  Christina Mundy; Evan Yang; Hajime Takano; Paul C Billings; Maurizio Pacifici
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

5.  Delineation of a contiguous gene syndrome with multiple exostoses, enlarged parietal foramina, craniofacial dysostosis, and mental retardation, caused by deletions in the short arm of chromosome 11.

Authors:  O Bartsch; W Wuyts; W Van Hul; J T Hecht; P Meinecke; D Hogue; W Werner; B Zabel; G K Hinkel; C M Powell; L G Shaffer; P J Willems
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

6.  Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.

Authors:  Beverly M Zak; Manuela Schuksz; Eiki Koyama; Christina Mundy; Dan E Wells; Yu Yamaguchi; Maurizio Pacifici; Jeffrey D Esko
Journal:  Bone       Date:  2011-02-15       Impact factor: 4.398

7.  Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses.

Authors:  C Philippe; D E Porter; M E Emerton; D E Wells; A H Simpson; A P Monaco
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

8.  Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.

Authors:  Caroline Bret; Dirk Hose; Thierry Reme; Anne-Catherine Sprynski; Karène Mahtouk; Jean-François Schved; Philippe Quittet; Jean-François Rossi; Hartmut Goldschmidt; Bernard Klein
Journal:  Br J Haematol       Date:  2009-03-02       Impact factor: 6.998

9.  The molecular and cellular basis of exostosis formation in hereditary multiple exostoses.

Authors:  Meirav Trebicz-Geffen; Dror Robinson; Zoharia Evron; Tova Glaser; Mati Fridkin; Yehuda Kollander; Israel Vlodavsky; Neta Ilan; Kit Fong Law; Kathryn S E Cheah; Danny Chan; Haim Werner; Zvi Nevo
Journal:  Int J Exp Pathol       Date:  2008-04-30       Impact factor: 1.925

10.  A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.

Authors:  Kevin B Jones; Virginia Piombo; Charles Searby; Gail Kurriger; Baoli Yang; Florian Grabellus; Peter J Roughley; Jose A Morcuende; Joseph A Buckwalter; Mario R Capecchi; Andrea Vortkamp; Val C Sheffield
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.